Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi

AIDS Education and Prevention

Volumn 20, Issue 2, 2008, Pages 171-187

  Woodsong, Cynthia ^a   Alleman, Patty ^b  

^a RTI INTERNATIONAL   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DISINFECTANT AGENT; EDIBLE OIL; MICROBICIDE; NATURAL PRODUCT; PETROLATUM; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTRIBUTABLE RISK; CLEANING; CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFECTION RISK; MAJOR CLINICAL STUDY; MALAWI; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; RISK REDUCTION; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; VAGINA PAIN; VAGINA SECRETION; WOMEN'S HEALTH; ZIMBABWE;

ANTI-INFECTIVE AGENTS, LOCAL; COITUS; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERPERSONAL RELATIONS; LIBIDO; MALAWI; MALE; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VAGINAL CREAMS, FOAMS, AND JELLIES; ZIMBABWE;

EID: 43549096180     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2008.20.2.171     Document Type: Article

References (58)

1. Alliance for Microbicide Development. (2007). Microbicides in ongoing and planned clinical trials. Retrieved November, 22, 2007, from http:// www.microbicide.org
2. Baleta, A. (1998). Concern voiced over "dry sex" practices in South Africa. The Lancet, 352(9136), 1292.
3. Bancroft, J. (1997). Researching sexual behavior: Methodological issues (Kinsey Institute Series No. v. 5). Bloomington: Indiana University Press.
4. Becker J., Dabash, R., McGrory, E., Cooper, D., & Harries, J. (2004). Paving the path: Preparing for microbicide introduction. Report of a qualitative study in South Africa. New York: Engender Health.
5. Bentley, M., Morrow, K., Fullem, A., Chesney, S., Rosenberg, Z., & Mayer, K. (2000). Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Family Planning Perspectives, 32(4), 184-188.
6. Bernard, H.R. (2002). Social Research Methods: qualitative and quantitative approaches, Thousand Oaks, CA: Sage.
7. Blanc, A. (2001). The effect of power in sexual relationships on sexual and reproductive health: An examination of the evidence. Studies in Family Planning, 32(3), 189-213.
8. Braunstein, S., & van de Wijgert, J. (2005). Preferences and practices related to vaginal lubrication: Implications for microbicide acceptability and clinical testing. Journal of Women's Health, 14(5), 424-433.
9. Brown, J., & Brown, R. (2000). Traditional intravaginal practices and the heterosexual transmission of disease: A review. Sexually Transmitted Diseases, 27(4), 183-187.
10. Catania, J. A., Kegeles, S.M., & Coates, T. J. (1990). Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM). Health Education Quarterly, 17(1), 53-72.
11. Chen, F. H. (2006). The impact of microbicides and changes in condom usage on HIV prevalence in men and women. AIDS, 20(11), 1551-1553.
12. Civic, D., & Wilson, D. (1996). Dry sex in Zimbabwe and implications for condom use. Social Science and Medicine, 42(1), 91-98.
13. Coggins, C., Elias, C., Atisook, R., Bassett, M.T., Ettiegne-Traore, Ghys, P.D., et al. (1998). Women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS, 12(11), 1389-1391.
14. Dixon-Mueller, R. (1993). The sexuality connection in reproductive health. Studies in Family Planning, 24(5), 269-282.
15. Elias, C., & Coggins, C. (2001). Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? Journal of Women's Health and Gender-Based Medicine, 10(2), 163-173.
16. Foss, A.M., Watts, C. H., Vickerman, P., & Heise, L. (2004). Condoms and prevention of HIV. British Medical Journal, 329(7459), 185-186.
17. Hammett, T. M., Mason, T. H., Joanis, C. L., Foster, S.E., Harmon, P., Robles, R.R., et al. (2000). Acceptability of formulations and applicationmethods for vaginal microbicides among drug-involved women: results of product trials in three cities. Sexually Transmitted Diseases, 27(2), 119-26.
18. Hardy, E., Jimenez, A. L., de Padua, K. S., & Zaneveld, L. J. (1998). Women's preferences for vaginal antimicrobial contraceptives III: Preferences for formulation, applicator, and packaging. Contraception, 58(4), 245-249.
19. Heise, L. (1997). Beyond acceptability: Reorienting research on contraceptive choice. Beyond acceptability: User's perspectives on contraception (pp. 6-14). London: Reproductive Health Matters.
20. Heise, L. L., McGrory, C. E., & Wood, S. Y. (1998). Practical and ethical dilemmas in the clinical testing of microbicides: A report on a symposium, New York: Population Council.
21. Higgins, J.A., & Hirsch, J.S. (2007). The pleasure deficit: Revisiting the "sexuality connection" in reproductive health. International Family Planning Perspectives, 33(3), 133-139.
22. Hilber, A.M. (2007, July). Prevalence and implications for vaginal microbicides: Preliminary results of the WHO Multi-country Study on Gender, Sexuality and Vaginal Practices. Paper presented at the Microbicides Access Form, Nairobi, Kenya.
23. Hira, S. K., Spruyt, A. B., Feldblum, P. J., Sunkutu, M.R., Glover, L.H., & Steiner, M.J. (1995). Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. American Journal of Public Health, 85(8 Pt 1), 1098-1103.
24. Kathewera-Banda, M., Gomile-Chidyaonga, F., Hendriks, S., Kachika, T., Mitole, Z., & White, S. (2005). Sexual violence and women's vulnerability to HIV transmission in Malawi : A rights issue. Oxford, England: UNESCO.
25. Lederman, M. M., Offord, R. E., & Hartley, O. (2006). Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nature Reviews Immunology, 6(5), 371-382.
26. Levin, R. (2005). Wet and dry sex - The impact of cultural influence in modifying vaginal function. Sexual and Relational Theory, 20(4), 465-477.
27. Logan, T., Cole, J., & Leukefeld, C. (2002). Women, sex, and HIV: Social and contextual factors, meta-analysis of published interventions, and implications for practice and research. Psychological Bulletin, 128(6), 851-885.
28. MacQueen, K. M., & Cates, W., Jr. (2005). The multiple layers of prevention science research. American Journal of Preventive Medicine, 28(5), 491-495.
29. MacQueen, K.M. McLellan-Lemal, E., Bartholow, K., & Milstein, B. (2008). Team-based codebook development: Structure, process and agreement. In G. Guest, and M. MacQueen (Eds.), Handbook for team-based qualitative research (pp. 119-136). Alta Mira Press.
30. Manderson, L., Bennett, L. R., & Sheldrake, M. (1999). Sex, social institutions, and social structure: Anthropological contributions to the study of sexuality. Annual Reviews of Sex Research, 10, 184-209.
31. Mantell, J. E., Myer, L., Carballo-Diéguez, A., Stein, Z., Ramjee, G. (2005). Microbicide acceptability research: current approaches and future directions. Social Science and Medicine, 60(2), 319-330.
32. McClelland, R. S., Lavreys, L., Hassan, W. M., Mandaliya, K. Ndinya-Achola, J.O. & Baeten, J.M. (2006). Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS, 20(2), 269-273.
33. Microbicide Trials Network. (n.d.). HPTN 035: Phase II/IIb safety and effectiveness study of the vaginal microbicides BufferGel and PRO2000/5 Gel (P) for the prevention of HIV infection in women. Retrieved Feb 22, 2008, from http://www.mtnstophiv.org
34. Morrow, J., Fava, J., Rosen, R., Vargas, S., Barroso, C., Christensen, A., et al. (2007). The importance of product characteristics, use and protection properties on willingness to use microbicides. Journal of AIDS, 45(1), 93-101.
35. Morrow, K., & Ruiz M. (2007). Assessing microbicide acceptability: A comprehensive approach. AIDS and Behavior.
36. Myer, L., Kuhn, L., Stein, Z. A., Wright, T.C., Jr., & Denny, L. (2005). Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: Epidemiological evidence and biological mechanisms. Lancet Infectious Diseases, 5(12), 786-794.
37. Padian, N. S., Shiboski, S. C., Glass, S. O., & Vittinghoff, E. (1997). Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study. American Journal of Epidemiology, 146(4), 350-357.
38. Pool, R., Whitworth, J., Green, G., Mbonye, A., Harrison, S., Hart, G., et al. (2002, May). Ambiguity, sexual pleasure, and the acceptability of microbicidal products in southwest Uganda. Paper presented at Microbicides 2002, Antwerp, Belgium.
39. Prochaska, J. R., Redding, C.A., Harlow, L.L., Rossi, J.S., & Velicer, W.F. (1994). The transtheoretical model of change and HIV prevention: A review. Health Education Quarterly, 21(4), 471-486.
40. Ray, S., Gumbo, N., & Mbizvo, M. (1996). Local voices: What some Harare men say about preparation for sex. Reproductive Health Matters, 7, 34-45.
41. Severy, L. J., & Newcomer, S. (2005). Critical issues in contraceptive and STI acceptability research. Journal of Social Issues, 61(1), 45-65.
42. Severy, L.J., Tolley, E.E., Woodsong, C., & Guest, G. (2005). A framework for examining sustained acceptability of microbicides. AIDS and Behavior, 61(1), 193-205.
43. Strauss, A.l., & Corbin, J. (1990). Basics of qualitative reseach: grounded theory procedures and Techniques. Newbury Park, CA : Sage.
44. Stein, Z. A., Myer, L., & Susser, M. (2003). The design of prophylactic trials for HIV: The case of microbicides. Epidemiology, 14(1), 80-83.
45. Tieffer, L. (1996). The medicalization of sexuality: Conceptual, normative, and professional issues. Annual Reviews of Sex Research, 7, 252-282.
46. Ulin, P. R., Robinson, E. T., & Tolley, E. E. (2005). Qualitative methods in public health: A field guide for applied research. San Francisco: Jossey-Bass.
47. UNAIDS. (2006). Report on the global HIV/AIDS epidemic, 2006. Geneva, Switzerland: Author.
48. UNAIDS & World Health Organization. (2006). UNAIDS/WHO AIDS Epidemic update: December 2006, Geneva, Switzerland: UNAIDS.
49. UNFPA. (2006). State of world population 2006. New York: Author.
50. van de Wijgert, J. H., Khumalo-Sakutukwa, G., Coggins, C., Dube, S.E., Nyamapfeni, P., Mwale, M., et al. (1999). Men's attitude toward vaginal microbicides and microbicide trials in Zimbabwe. International Family Planning Perspectives, 25(1), 15-20.
51. Vandebosch, A., Goetghebeur, E., Ramjee, G., Alary, M., Ettiègne-Traoré, V., Chandeying, V. et al. (2004). Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities. Sexually Transmitted Infections, 80(3), 241-243.
52. Veldhuijzen, N., Nyinawabega, J., Umulisa, M., Kankindi, B., Geubbels, E., Basinga, P., et al. (2006). Preparing for microbicide trials in Rwanda: Focus group discussions with Rwandan women and men. Culture, Health and Sexuality, 8(5), 395-406.
53. Wawer, M.J., Gray, R., Sewankambo, L., Serwadda, D., Li, X., Laeyendecker, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection in Rakai, Uganda. Journal of Infectious Diseases, 191, 1403-1409.
54. Weber R. (1990). Basic content analysis (2nd ed.) Thousand Oaks, CA: Sage.
55. Woodsong, C. (2004). Covert use of topical microbicides: Implications for acceptability and use. International Family Planning Pespectives, 30(2), 94-98.
56. Woodsong, C., MacQueen, K., Namey, E. Sahay, S., Mlingo, M., Morrar, N., et al. (2006). Women's autonomy and informed consent in international microbicide clinical trials. Journal of Empirical Research on Human Research Ethics, 1(3), 11-26.
57. Woodsong, C., & Severy, L. (2005). generation of knowledge for reproductive health technologies: Constraints on social and behavioral research. Journal of Social Issues, 61(1), 193-205.
58. World Bank. (2004). World development indicators 2004. Washington, DC: Author.